Article Information
History
- November 21, 2023.
Article Versions
- Version 1 (August 16, 2023 - 20:13).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Seth A. Reasoner1,*,
- Rachel Bernard2,*,
- Adam Waalkes3,
- Kelsi Penewit3,
- Janessa Lewis3,
- Andrew G. Sokolow4,
- Rebekah F. Brown4,
- Kathryn M. Edwards5,
- Stephen J. Salipante3,
- Maria Hadjifrangiskou1,6,7 and
- Maribeth R. Nicholson2,7,#
- 1Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
- 2Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Monroe Carrell Junior Children’s Hospital at Vanderbilt, Nashville, TN, USA
- 3Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
- 4Division of Allergy, and Immunology, and Pulmonary Medicine, Department of Pediatrics, Monroe Carrell Junior Children’s Hospital at Vanderbilt, Nashville, TN, USA
- 5Division of Infectious Diseases, Department of Pediatrics, Monroe Carrell Junior Children’s Hospital at Vanderbilt, Nashville, Tennessee, USA
- 6Center for Personalized Microbiology (CPMi), Vanderbilt University Medical Center, Nashville, TN, USA
- 7Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
- ↵#Corresponding Author:
Maribeth R. Nicholson, MD, MPH, Monroe Carell Jr. Children’s Hospital at Vanderbilt 2200 Children’s Way, Nashville, TN 37232, Telephone: +1 615 322 7449, E-mail: maribeth.r.nicholson{at}vumc.org
↵* These authors contributed equally to this work. Authorship position was determined by relative contributions made to this manuscript’s completion.
Posted November 21, 2023.
Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor
